Medications

Pembrolizumab + standard chemotherapy beneficial in mesothelioma

The addition of pembrolizumab to standard platinum-pemetrexed chemotherapy results in significant improvement in overall survival among patients with advanced pleural mesothelioma, according to a study published online Nov. ...

Diseases, Conditions, Syndromes

Wegovy cuts heart risks by 20% in large trial

In a finding that could change the landscape of heart disease care, the wildly popular weight-loss drug Wegovy has proved its mettle in protecting the heart after lowering the risk of cardiac problems in patients by 20%.

page 10 from 40